Drug Profile
S 111
Alternative Names: S111; YuxintineLatest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator Shanghai Innovative Research Center of Traditional Chinese Medicine
- Class Antidepressants; Spirostans; Traditional Chinese medicine
- Mechanism of Action Adrenergic receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for preclinical development in Major depressive disorder in China (PO, Capsule)
- 07 Jan 2016 Preclinical trials in Major depressive disorder in China (PO)